Remove Food and Drug Administration Remove Healthcare Provider Remove Recruitment Remove Safety
article thumbnail

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restoration System

Legacy MEDSearch

Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AccuCinch ® Ventricular Restoration System. This program is designed to ensure patients and healthcare providers have more timely access to these medical devices. Food and Drug Administration.

article thumbnail

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

Impetus Digital

We know from real-world evidence that drug efficacy and safety can differ based on age, sex, race, and ethnicity; these discrepancies may jeopardize treatment outcomes in undertested groups. Many clinical trials are struggling to recruit diverse participants, particularly from rural or remote areas far from large academic hospitals.

Pharma 90
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is it enough? Pharma addresses DE&I in clinical trials

Clarify Health

However, some communities have historically been underrepresented in clinical research due to barriers like a lack of access, awareness, and trust in drug development processes. Community leaders, such as educators, faith-based leaders, health workers, and healthcare providers, can be crucial to delivering the health information people need.

Pharma 40
article thumbnail

Is it enough? Pharma addresses DE&I in clinical trials

Clarify Health

However, some communities have historically been underrepresented in clinical research due to barriers like a lack of access, awareness, and trust in drug development processes. Community leaders, such as educators, faith-based leaders, health workers, and healthcare providers, can be crucial to delivering the health information people need.

Pharma 40